A genome-wide association study of brain lesion distribution in multiple sclerosis

Brain

Volumn 136, Issue 4, 2013, Pages 1012-1024

  Gourraud, Pierre Antoine ^a   Sdika, Michael ^a   Khankhanian, Pouya ^a   Henry, Roland G ^a   Beheshtian, Azadeh ^a   Matthews, Paul M ^b,c   Hauser, Stephen L ^a   Oksenberg, Jorge R ^a   Pelletier, Daniel ^a,d   Baranzini, Sergio E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GWAS; multiple sclerosis; voxel wise

Indexed keywords

ADULT; ARTICLE; BRAIN DAMAGE; FEMALE; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROBABILITY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84876016091     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws363     Document Type: Article

References (64)

1. Aruga J. Slitrk6 expression profile in the mouse embryo and its relationship to that of Nlrr3. Gene Expr Patterns 2003; 3: 727-33.
2. Aruga J, Mikoshiba K. Identification and characterization of Slitrk, a novel neuronal transmembrane protein family controlling neurite outgrowth. Mol Cell Neurosci 2003; 24: 117-29.
3. Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, Pelletier D, et al. Pathway and network-based analysis of genomewide association studies in multiple sclerosis. Hum Mol Genet 2009a; 18: 2078-90.
4. Baranzini SE, Srinivasan R, Khankhanian P, Okuda DT, Nelson SJ, Matthews PM, et al. Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain 2010; 133: 2603-11.
5. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009b; 18: 767-78.
6. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004; 55: 458-68.
7. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995; 57: 289-300.
8. Biffi A, Anderson CD, Desikan RS, Sabuncu M, Cortellini L, Schmansky N, et al. Genetic variation and neuroimaging measures in Alzheimer disease. Arch Neurol 2010; 67: 677-85.
9. Blum D, Yonelinas AP, Luks T, Newitt D, Oh J, Lu Y, et al. Dissociating perceptual and conceptual implicit memory in multiple sclerosis patients. Brain Cogn 2002; 50: 51-61.
10. Brett M, Leff AP, Rorden C, Ashburner J. Spatial normalization of brain images with focal lesions using cost function masking. Neuroimage 2001; 14: 486-500.
11. Charil A, Zijdenbos AP, Taylor J, Boelman C, Worsley KJ, Evans AC, et al. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 2003; 19: 532-44.
12. Cheung VG, Spielman RS. The genetics of variation in gene expression. Nat Genet 2002; 32 (Suppl): 522-5.
13. De Moor MH, Liu YJ, Boomsma DI, Li J, Hamilton JJ, Hottenga JJ, et al. Genome-wide association study of exercise behavior in Dutch and American adults. Med Sci Sports Exerc 2009; 41: 1887-95.
14. Enzinger C, Smith S, Fazekas F, Drevin G, Ropele S, Nichols T, et al. Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study. J Neurol 2006; 253: 1064-70.
15. Eriksson N, Macpherson JM, Tung JY, Hon LS, Naughton B, Saxonov S, et al. Web-based, participant-driven studies yield novel genetic associations for common traits. PLoS Genet 2010; 6: e1000993.
16. Gaitan MI, Shea CD, Evangelou IE, Stone RD, Fenton KM, Bielekova B, et al. Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann Neurol 2011; 70: 22-9.
17. Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006; 52: 61-76.
18. Hauser SL, Oksenberg JR, Lincoln R, Garovoy J, Beck RW, Cole SR, et al. Optic Neuritis Study Group. Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Neurology 2000; 54: 1859-61.
19. Henry RG, Shieh M, Amirbekian B, Chung S, Okuda DT, Pelletier D. Connecting white matter injury and thalamic atrophy in clinically isolated syndromes. J. Neurol Sci 2009; 282: 61-6.
20. Hibar DP, Stein JL, Kohannim O, Jahanshad N, Saykin AJ, Shen L, et al. Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects. Neuroimage 2011; 56: 1875-91.
21. Hicks AA, Pramstaller PP, Johansson A, Vitart V, Rudan I, Ugocsai P, et al. Genetic determinants of circulating sphingolipid concentrations in European populations. PLoS Genet 2009; 5: e1000672.
22. Horakova D, Zivadinov R, Weinstock-Guttman B, Havrdova E, Tamano- Blanco M, Tyblova M, et al. HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event. J. Neuroimmunol 2011; 236: 76-80.
23. Ideker T, Ozier O, Schwikowski B, Siegel AF. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 2002; 18 (Suppl 1): S233-40.
24. Kim JG, Armstrong RC, v Agoston D, Robinsky A, Wiese C, Nagle J, et al. Myelin transcription factor 1 (Myt1) of the oligodendrocyte lineage, along with a closely related CCHC zinc finger, is expressed in developing neurons in the mammalian central nervous system. J Neurosci Res 1997; 50: 272-90.
25. Kutalik Z, Whittaker J, Waterworth D, Beckmann JS, Bergmann S. Novel method to estimate the phenotypic variation explained by genome-wide association studies reveals large fraction of the missing heritability. Genet Epidemiol 2011; 35: 341-9.
26. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010; 467: 832-8.
27. Lassmann H. A dynamic view of the blood-brain barrier in active multiple sclerosis lesions. Ann Neurol 2011; 70: 1-2.
28. Lebouvier T, Scales TM, Williamson R, Noble W, Duyckaerts C, Hanger DP, et al. The microtubule-associated protein tau is also phosphorylated on tyrosine. J Alzheimers Dis 2009; 18: 1-9.
29. Llorens F, Gil V, Iraola S, Carim-Todd L, Marti E, Estivill X, et al. Developmental analysis of Lingo-1/Lern1 protein expression in the mouse brain: interaction of its intracellular domain with Myt1l. Dev Neurobiol 2008; 68: 521-41.
30. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-7.
31. Medland SE, Zayats T, Glaser B, Nyholt DR, Gordon SD, Wright MJ, et al. A variant in LIN28B is associated with 2D:4D finger-length ratio, a putative retrospective biomarker of prenatal testosterone exposure. Am J Hum Genet 2010; 86: 519-25.
32. Miller MI, Christensen GE, Amit Y, Grenander U. Mathematical textbook of deformable neuroanatomies. Proc Natl Acad Sci USA 1993; 90: 11944-8.
33. Mochida GH, Mahajnah M, Hill AD, Basel-Vanagaite L, Gleason D, Hill RS, et al. A truncating mutation of TRAPPC9 is associated with autosomal-recessive intellectual disability and postnatal microcephaly. Am J Hum Genet 2009; 85: 897-902.
34. Mowry EM, Beheshtian A, Waubant E, Goodin DS, Cree BA, Qualley P, et al. Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures. Neurology 2009; 72: 1760-5.
35. Nan H, Kraft P, Qureshi AA, Guo Q, Chen C, Hankinson SE, et al. Genome-wide association study of tanning phenotype in a population of European ancestry. J Invest Dermatol 2009; 129: 2250-7.
36. Narayanan S, Fu L, Pioro E, De Stefano N, Collins DL, Francis GS, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997; 41: 385-91.
37. Negro A, Brunati AM, Donella-Deana A, Massimino ML, Pinna LA. Multiple phosphorylation of alpha-synuclein by protein tyrosine kinase Syk prevents eosin-induced aggregation. FASEB J 2002; 16: 210-12.
38. Newton-Cheh C, Eijgelsheim M, Rice KM, de Bakker PI, Yin X, Estrada K, et al. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet 2009; 41: 399-406.
39. Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini SE, Beheshtian A, et al. Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain 2009; 132 (Pt 1): 250-9.
40. Philippe O, Rio M, Carioux A, Plaza JM, Guigue P, Molinari F, et al. Combination of linkage mapping and microarray-expression analysis identifies NF-kappaB signaling defect as a cause of autosomal-recessive mental retardation. Am J Hum Genet 2009; 85: 903-8.
41. Potkin SG, Turner JA, Fallon JA, Lakatos A, Keator DB, Guffanti G, et al. Gene discovery through imaging genetics: identification of two novel genes associated with schizophrenia. Mol Psychiatry 2009a; 14: 416-28.
42. Potkin SG, Turner JA, Guffanti G, Lakatos A, Torri F, Keator DB, et al. Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations. Cogn Neuropsychiatry. 2009b; 14: 391-418.
43. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-75.
44. Rueckert D, Aljabar P, Heckemann RA, Hajnal JV, Hammers A. Diffeomorphic registration using B-splines. Med Image Comput Comput Assist Interv 2006; 9 (Pt 2): 702-9.
45. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011; 476: 214-9.
46. Sdika M. A fast nonrigid image registration with constraints on the Jacobian using large scale constrained optimization. IEEE Trans Med Imaging 2008; 27: 271-81.
47. Sdika M, Pelletier D. Nonrigid registration of multiple sclerosis brain images using lesion inpainting for morphometry or lesion mapping. Hum Brain Mapp 2009; 30: 1060-7.
48. Severance EG, Yolken RH. Lack of RIC-3 congruence with beta2 subunit-containing nicotinic acetylcholine receptors in bipolar disorder. Neuroscience 2007; 148: 454-60.
49. Shen L, Kim S, Risacher SL, Nho K, Swaminathan S, West JD, et al. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: a study of the ADNI cohort. Neuroimage 2010; 53: 1051-63.
50. Shimomura R, Sakai K, Tanaka Y, Yonezawa K, Hashimoto E, Kasuga M, et al. Phosphorylation sites of myelin basic protein by a catalytic fragment of non-receptor type protein-tyrosine kinase p72syk and comparison with those by insulin receptor kinase. Biochem Biophys Res Commun 1993; 192: 252-60.
51. Siegmund KD, Connor CM, Campan M, Long TI, Weisenberger DJ, Biniszkiewicz D, et al. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE 2007; 2: e895.
52. Sombekke MH, Vellinga MM, Uitdehaag BM, Barkhof F, Polman CH, Arteta D, et al. Genetic correlations of brain lesion distribution in multiple sclerosis: an exploratory study. AJNR Am J Neuroradiol 2011; 32: 695-703.
53. Sondag CM, Dhawan G, Combs CK. Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J Neuroinflammation 2009; 6: 1.
54. Stein JL, Hua X, Lee S, Ho AJ, Leow AD, Toga AW, et al. Voxelwise genome-wide association study (vGWAS). Neuroimage 2010; 53: 1160-74.
55. Sulem P, Gudbjartsson DF, Stacey SN, Helgason A, Rafnar T, Jakobsdottir M, et al. Two newly identified genetic determinants of pigmentation in Europeans. Nat Genet 2008; 40: 835-7.
56. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010; 466: 707-13.
57. van der Sluis S, Verhage M, Posthuma D, Dolan CV. Phenotypic complexity, measurement bias, and poor phenotypic resolution contribute to the missing heritability problem in genetic association studies. PLoS ONE 2010; 5: e13929.
58. Vana AC, Lucchinetti CF, Le TQ, Armstrong RC. Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS. Glia 2007; 55: 687-97.
59. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010; 463: 1035-41.
60. Vilarino-Guell C, Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, et al. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics 2010; 11: 401-8.
61. Vrijenhoek T, Buizer-Voskamp JE, van der Stelt I, Strengman E, Sabatti C, Geurts van Kessel A, et al. Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am J Hum Genet 2008; 83: 504-10.
62. Waxman SG. From neuroscience to neurology: neuroscience, molecular medicine, and the therapeutic transformation of neurology. Amsterdam; Boston: Elsevier Academic Press; 2005.
63. Wood AR, Hernandez DG, Nalls MA, Yaghootkar H, Gibbs JR, Harries LW, et al. Allelic heterogeneity and more detailed analyses of known loci explain additional phenotypic variation and reveal complex patterns of association. Hum Mol Genet 2011; 20: 4082-92.
64. Wrathall JR, Li W, Hudson LD. Myelin gene expression after experimental contusive spinal cord injury. J Neurosci 1998; 18: 8780-93.